Broadstone Net Lease (BNL) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
9 Dec, 2025Executive summary
Achieved AFFO per share of $1.43 for 2024, at the top end of guidance, with 1.4% year-over-year growth, $400M+ in total investments, and near-completion of healthcare portfolio simplification, reducing clinical/surgical assets to 3.2% of ABR from 9.7%.
Maintained a high-quality, diversified portfolio of 765 properties, 99%+ leased and rent collection rate, with no tenant accounting for more than 4.1% of ABR.
Board changes include the departure of two directors and the addition of Rick Imperiale and Joe Saffire, enhancing REIT and operational expertise.
Financial highlights
Generated $282 million AFFO for the year ($1.43/share), up 1.4% year-over-year, benefiting from timely redeployment of healthcare disposition proceeds and lower G&A and interest expenses.
Full year 2024 net income was $169.0M ($0.86/share), up 3.6% year-over-year; Q4 AFFO was $70.5M ($0.36/share), flat year-over-year.
Revenues for 2024 were $431.8M, down from $442.9M in 2023.
Core G&A totaled $29.3M for the year, with cost savings from personnel changes and lower insurance premiums.
Maintained a $0.29 per share dividend, well covered and yielding attractively versus peers.
Outlook and guidance
2025 AFFO guidance is $1.45–$1.49 per share, representing ~3% growth at the midpoint, based on $400M–$600M in investments and $50M–$100M in dispositions.
No plans to raise equity in 2025; funding to come from revolver, retained earnings, and accretive dispositions.
Core G&A expenses expected between $30M and $31M for 2025.
$200M+ in build-to-suit developments scheduled for completion in 2025–2026.
Expect to provide 2026–2027 run-rate growth preview later in 2025.
Latest events from Broadstone Net Lease
- AFFO per share rose 4.2% to $1.49 in 2025, with 99.8% occupancy and steady 2026 guidance.BNL
Q4 202519 Feb 2026 - AFFO rose 2.9% YoY as healthcare exits funded high-yield investments and guidance remained strong.BNL
Q2 20242 Feb 2026 - AFFO guidance held at $1.41–$1.43 as healthcare exposure drops below 10% of ABR.BNL
Q3 202417 Jan 2026 - AFFO steady, strong leasing and liquidity, but net income fell on lower property sale gains.BNL
Q1 202523 Dec 2025 - Industrial focus and BTS pipeline drive 4% AFFO growth and 7.6% NOI CAGR outlook through 2027.BNL
Investor Day 2025 Presentation2 Dec 2025 - Diversified net lease REIT delivers strong growth, high occupancy, and robust build-to-suit pipeline.BNL
Investor Presentation2 Dec 2025 - Annual meeting to vote on directors, executive pay, auditor, and review strong 2024 results.BNL
Proxy Filing1 Dec 2025 - Annual meeting to elect directors, approve pay, and ratify auditor set for May 1, 2025.BNL
Proxy Filing1 Dec 2025 - AFFO guidance raised after 5.6% Q2 growth and 99.1% occupancy amid strong investment activity.BNL
Q2 202516 Nov 2025